Early chronic low-level lead exposure produces glomerular hypertrophy in young C57BL/6J mice

Toxicology Letters

Volumn 225, Issue 1, 2014, Pages 48-56

  Basgen, John M ^a   Sobin, Christina ^b,c  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF TEXAS AT EL PASO   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Capillary volume; Design based stereology; Glomerular hypertrophy; Mesangial volume; Pb toxicity

Indexed keywords

DRINKING WATER; LEAD;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIRTH; CONTROLLED STUDY; GLOMERULUS; GLOMERULUS CAPILLARY; KIDNEY HYPERTROPHY; LEAD BLOOD LEVEL; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL;

ANIMALIA; MUS;

CAPILLARY VOLUME; DESIGN-BASED STEREOLOGY; GLOMERULAR HYPERTROPHY; MESANGIAL VOLUME; PB TOXICITY;

AGE FACTORS; ANIMALS; CAPILLARIES; FEMALE; HYPERTROPHY; KIDNEY DISEASES; KIDNEY GLOMERULUS; LEAD POISONING; MALE; MESANGIAL CELLS; MICE; MICE, INBRED C57BL; PODOCYTES; TIME FACTORS;

EID: 84890373100     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2013.11.031     Document Type: Article

References (46)

1. Azzaoui F.Z., Ahami A.O., Khadmaoui A. Impact of lead sub-chronic toxicity on recognition memory and motor activity of Wistar rat. Pak. J. Biol. Sci. 2009, 12:173-177.
2. Bai X.Y., Basgen J.M. Podocyte number in the maturing rat kidney. Am. J. Nephrol. 2011, 33:91-96.
3. Cain J.E., Di Giovanni V., Smeeton J., Rosenblum N.D. Genetics of renal hypoplasia: insights into the mechanisms controlling nephron endowment. Pediatr. Res. 2010, 68:91-98.
4. Carroll T., Das A. Defining the signals that constitute the nephron progenitor niche. Am. J. Kidney Dis. 2013, 24:873-876.
5. Ciuffo G.M., Viswanathan M., Seltzer A.M., Tsutsumi K., Saavedra J.M. Glomerular angiotensin II receptor subtypes during development of rat kidney. Am. J. Physiol. 1993, 265:F264-F271.
6. de Burbure C., Buchet J.P., Leroyer A., Nisse C., Haguenoer J.M., Mutti A., Smerhovsky Z., Cikrt M., Trzcinka-Ochocka M., Razniewska G., Jakubowski M., Bernard A. Renal and neurologic effects of cadmium, lead, mercury, and arsenic in children: evidence of early effects and multiple interactions at environmental exposure levels. Environ. Health Perspect. 2006, 114:584-590.
7. de Vriese A.S., Tilton R.G., Elger M., Stephan C.C., Kriz W., Lameire N.H. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J. Am. Soc. Nephrol. 2001, 12:993-1000.
8. Ekong E.B., Jaar B.G., Weaver V.M. Lead-related nephrotoxicity: a review of the epidemiologic evidence. Kidney Int. 2006, 70:2074-2084.
9. Fadrowski J.J., Navas-Acien A., Tellez-Plaza M., Guallar E., Weaver V.M., Furth S.L. Blood lead level and kidney function in us adolescents: the third national health and nutrition examination survey. Arch. Intern. Med. 2010, 170:75-82.
10. Fels L., Wunsch M., Baranowski J., Norska-Borowka I., Price R., Taylor S., Patel S., De Broe M., Elsevier M., Lauwerys R., Roels H., Bernard A., Mutti A., Gelpi E., Rosello J., Stolte H. Adverse effects of chronic low level lead exposure on kidney function-a risk group study in children. Nephrol. Dial. Transpl. 1998, 13:2248-2256.
11. Ferguson S.A., Bowman R.E. Effects of postnatal lead exposure on open field behavior in monkeys. Neurotoxicol. Teratol. 1990, 12:91-97.
12. Flyvbjerg A.D.-H.F., DeVriese A.S., Schrijvers B.F., Tilton R.G., Rasch R. Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes 2002, 51:3090-3094.
13. Greka A., Mundel P. Cell biology and pathology of podocytes. Annu. Rev. Physiol. 2012, 74:299-323. 10.1146/annurev-physiol-020911-153238.
14. Hattori M., Kim Y., Steffes M.W., Mauer S.M. Structural-functional relationships in type I mesangiocapillary glomerulonephritis. Kidney Int. 1993, 43:381-386.
15. Hirose K., Tsuchida H., Osterby R., Gundersen H.J. A strong correlation between glomerular filtration rate and filtration surface in diabetic kidney hyperfunction. Lab. Invest. 1980, 43:434-437.
16. Hossain M.A., Bouton C.M., Pevsner J., Laterra J. Induction of vascular endothelial growth factor in human astrocytes by lead Involvement of a protein kinase C/activator protein-1 complex-dependent and hypoxia-inducible factor 1-independent signaling pathway. J. Biol. Chem. 2000, 275:27874-27882.
17. Hossain M.A., Russell J.C., Miknyoczki S., Ruggeri B., Lal B., Laterra J. Vascular endothelial growth factor mediates vasogenic edema in acute lead encephalopathy. Ann. Neurol. 2004, 55:660-667.
18. Hsu C.Y., Lin F., Vittinghoff E., Shlipak M.G. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J. Am. Soc. Nephrol. 2003, 14:2902-2907.
19. Jerums G., Premaratne E., Panagiotopoulos S., MacIsaac R.J. The clinical significance of hyperfiltration in diabetes. Diabetologia 2010, 53:2093-2104. 10.1007/s00125-010-1794-9.
20. Kasten-Jolly J., Pabello N., Bolivar V.J., Lawrence D.A. Developmental lead effects on behavior and brain gene expression in male and female BALB/cAnNTac mice. Neurotoxicology 2012, 33:1005-1020. 10.1016/j.neuro.2012.04.017.
21. Keller G., Zimmer G., Mall G., Ritz E., Amann K. Nephron number in patients with primary hypertension. N. Engl. J. Med. 2003, 348:101-108.
22. Lanphear B.P., Hornung R., Ho M., Howard C.R., Eberly S., Knauf K. Environmental lead exposure during early childhood. J. Pediatr. 2002, 140:40-47.
23. Leasure J.L., Giddabasappa A., Chaney S., Johnson J.E., Pothakos K., Lau Y.S., Fox D.A. Low-level human equivalent gestational lead exposure produces sex-specific motor and coordination abnormalities and late-onset obesity in year-old mice. Environ. Health Perspect. 2008, 116:355-361.
24. Lidsky T.I., Schneider J.S. Lead neurotoxicity in children: basic mechanisms and clinical correlates. Brain 2003, 126:5-19.
25. Liu A., Dardik A., Ballermann B.J. Neutralizing TGF-beta1 antibody infusion in neonatal rat delays in vivo glomerular capillary formation 1. Kidney Int. 1999, 56:1334-1348.
26. Nagata M., Scharer K., Kriz W. Glomerular damage after uninephrectomy in young rats I. Hypertrophy and distortion of capillary architecture. Kidney Int. 1992, 42:136-147.
27. Nyengaard J.R. Stereologic methods and their application in kidney research. J. Am. Soc. Nephrol. 1999, 10:1100-1123.
28. Nyengaard J.R., Rasch R. The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes. Diabetologia 1993, 36:189-194.
29. Okada R., Yasuda Y., Tsushita K., Wakai K., Hamajima N., Matsuo S. Glomerular hyperfiltration in prediabetes and prehypertension. Nephrol. Dial. Transpl. 2012, 27:1821-1825. 10.1093/ndt/gfr651.
30. Østerby R., Gundersen H.J. Glomerular size and structure in diabetes mellitus. I. Early abnormalities. Diabetologia 1975, 11:225-229.
31. Palatini P., Dorigatti F., Saladini F., Benetti E., Mos L., Mazzer A., Zanata G., Garavelli G., Casiglia E. Factors associated with glomerular hyperfiltration in the early stage of hypertension. Am. J. Hypertens. 2012, 25:1011-1016. 10.1038/ajh.2012.73.
32. Peppa M., Brem H., Cai W., Zhang J.G., Basgen J., Li Z., Vlassara H., Uribarri J. Prevention and reversal of diabetic nephropathy in db/db mice treated with alagebrium (ALT-711). Am. J. Nephrol. 2006, 26:430-436.
33. Reeves W., Caulfield J.P., Farquhar M.G. Differentiation of epithelial foot processes and filtration slits: sequential appearance of occluding junctions, epithelial polyanion, and slit membranes in developing glomeruli. Lab. Invest. 1978, 39:90-100.
34. Reiter L.W., Anderson G.E., Laskey J.W., Cahill D.F. Developmental and behavioral changes in the rat during chronic exposure to lead. Environ. Health Perspect. 1975, 12:119-123.
35. Schreuder M. Safety in glomerular numbers. Pediatr. Nephrol. 2012, 27:1881-1887.
36. Seyer-Hansen K., Hansen J., Gundersen H.J. Renal hypertrophy in experimental diabetes. A morphometric study. Diabetologia 1980, 18:501-505.
37. Sobin C., Montoya M.G., Parisi N., Schaub T., Cervantes M., Armijos R.X. Microglial disruption in young mice with early chronic lead exposure. Toxicol. Lett. 2013, 15:151-153.
38. Sobin C., Parisi N., Schaub T., de la Riva E. A Bland-Altman comparison of the Lead Care(R) System and inductively coupled plasma mass spectrometry for detecting low-level lead in child whole blood samples. J. Med. Toxicol. 2011, 7:24-32. 10.1007/s13181-13010-10113-13187.
39. Sobin C., Parisi N., Schaub T., Gutierrez M., Ortega A.X. δ-Aminolevulinic acid dehydratase single nucleotide polymorphism 2 and peptide transporter 2*2 haplotype may differentially mediate lead exposure in male children. Arch. Environ. Contam. Toxicol. 2011, 61(3):521-529.
40. Spector J., Navas-Acien A., et al. Associations of blood lead with estimated glomerular filtration rate using MDRD, CKD-EPI and serum cystatin C-based equations. Nephrol. Dial. Transpl. 2011, 26:2786-2792.
41. Staessen J., Yeoman W.B., Fletcher A.E., Markowe H.L., Marmot M.G., Rose G., Semmence A., Shipley M.J., Bulpitt C.J. Blood lead concentration, renal function, and blood pressure in London civil servants. Br. J. Ind. Med. 1990, 47:442-447.
42. Steenland K., Selevan S., Landrigan P. The mortality of lead smelter workers: an update. Am. J. Public Health 1992, 82:1641-1644.
43. Suzuki H., Tokuriki T., Saito K., Hishida A., Suzuki K. Glomerular hyperfiltration and hypertrophy in the rat hypoplastic kidney as a model of oligomeganephronic disease. Nephrol. Dial. Transplant. 2005, 20:1362-1369.
44. Weibel E.R. Stereological Methods, Vol. 1, Practical Methods for Biological Morphometry 1979, Academic Press.
45. Ziegler E.E., Edwards B.B., Jensen R.L., Mahaffey K.R., Fomon S.J. Absorption and retention of lead by infants. Pediatr. Res. 1978, 12:29-34.
46. Zuscik M.J., Ma L., Buckley T., Puzas J.E., Drissi H., Schwarz E.M., O'Keefe R.J. Lead induces chondrogenesis and alters transforming growth factor-beta and bone morphogenetic protein signaling in mesenchymal cell populations. Environ. Health Perspect. 2007, 115:1276-1282.